A Novel Stimulation Protocol and the Conventional Low Dose Step-up and Step Down Regimens
Launched by GENESIS CENTER FOR FERTILITY & HUMAN PRE-IMPLANTATION GENETICS · Apr 26, 2010
Trial Information
Current as of May 07, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Failure to ovulate after CC treatment
- • Over than 30 years of age No Previous IVF attempts
- • Patent Fallopian Tubes
- • Normo-spermic partners
- Exclusion Criteria:
- • Secondary Infertility
- • Younger than 30 years
- • Older than 36 years
- • Other infertility cause
About Genesis Center For Fertility & Human Pre Implantation Genetics
Genesis Center for Fertility & Human Pre-Implantation Genetics is a leading clinical trial sponsor dedicated to advancing reproductive health through innovative research and cutting-edge genetic technologies. Specializing in fertility treatments and pre-implantation genetic diagnosis (PGD), the center focuses on improving outcomes for individuals and couples facing infertility challenges. With a team of experts in reproductive medicine and genetics, Genesis Center aims to enhance the understanding of human embryonic development and the genetic factors influencing successful pregnancies. Committed to patient-centered care and ethical research practices, the center actively collaborates with academic institutions and industry partners to drive breakthroughs in fertility science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Limassol, , Cyprus
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials